Pharma

Providence recently launched a program to expand its patients’ access to in-home physical therapy. The health system is...

Pear Therapeutics isn’t meeting the commercialization goals for its prescription digital therapeutics, so it’s now seeking...

Patricia Kelmar, healthcare campaigns director at the Public Interest Research Group, is an advocate for the No Surprises...

Without a new set of tools that clinicians can access at the point of care, the availability of information from QHINs will...

CMS should honor its commitment to Medicare beneficiaries, especially those who began home respiratory therapy under the...

CMS put out a request for information in October about a CMS-led national provider directory that would allow patients to...

Enzo BioChem’s sale of its clinical lab business to Labcorp is the culmination of a monthslong strategic review. Meanwhile,...

Perspectum — a company that makes medical imaging devices designed to improve the diagnosis of metabolic diseases and...

Pharmanovia and Aeterna Zentaris have entered an exclusive licensing agreement for the latter’s medicine Ghryvelin...

As the field of digital therapeutics continues to broaden, specific uses in mental health and neurology are increasingly...

Over the last twenty years, there has been a major rise in risk sharing agreements in the pharmaceutical space, said Alex...

GOSH will collaborate with Leucid at the Zayed Centre for Research into Rare Disease in Children

Therapy prevents tumour proliferation while breaking immune tolerance among cancer patients

The Lung Cancer Research Foundation (LCRF) has announced a new research partnership with Daiichi Sankyo and AstraZeneca....

The US Food and Drug Administration (FDA) has granted approval for Novartis’ combination therapy, Tafinlar (dabrafenib) and...